Obstructive sleep apnea and insulin resistance: a role for microcirculation?
Nicolas Wiernsperger1, Pierre Nivoit, Eliete Bouskela
1Department of Physiological Sciences, State University of Rio de Janeiro, Brazil.
Clinics (Sao Paulo, Brazil)
|July 13, 2006
Summary
Obstructive sleep apnea (OSA) may cause metabolic syndrome, not just accompany it. This review explores how OSA induces insulin resistance, hypertension, and heart failure, possibly via microcirculation changes.
Area of Science:
- Cardiology
- Endocrinology
- Sleep Medicine
Background:
- Obstructive sleep apnea (OSA) is a growing health concern.
- While linked to obesity and diabetes, new evidence suggests OSA may initiate metabolic disturbances.
- OSA's role in metabolic syndrome is increasingly recognized.
Purpose of the Study:
- To review established and potential mechanisms linking OSA to metabolic and vascular issues.
- To explore OSA as a potential primary cause of metabolic syndrome.
- To propose microcirculation as a unifying factor in OSA-related pathology.
Main Methods:
- Review of existing literature on OSA, metabolic syndrome, and cardiovascular function.
- Analysis of proposed pathophysiological mechanisms.
- Discussion of preclinical and clinical research protocols.
Main Results:
- OSA presents elements that can induce insulin resistance, hypertension, and heart failure.
- A strong bidirectional relationship between OSA and metabolic disturbances is suggested.
- Microcirculation is proposed as a central mediator for OSA-induced pathology.
Conclusions:
- OSA may be a primary driver of metabolic syndrome and related conditions.
- Microcirculatory dysfunction is a plausible common pathway.
- Further research using noninvasive techniques is warranted to validate these findings.
Related Concept Videos
01:21Sleep Apnea
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...